Madeline Renbarger's profile photo

Madeline Renbarger

New York

Reporter at Newcomer

Covering venture capital and startups news for Newcomer with @ericnewcomer // Past: @businessinsider // DM me for contact info

Articles

  • 1 week ago | newcomer.co | Madeline Renbarger

    Paid subscribers get access to a table with the top venture AI roll-ups at the bottom of this post in addition to our in-depth reporting on deal activity. Subscribe to read the full story and see our reporting on the key AI roll-ups. The AI roll-up has officially gone mainstream. Large VC firms like General Catalyst, Thrive Capital, and 8VC are increasingly running the private equity playbook of buying legacy businesses and trying to improve their performance.

  • 2 weeks ago | newcomer.co | Jonathan Weber |Madeline Renbarger

    The Week in ShortSam Altman and what it takes to be the next Steve Jobs. Behind the paywall: Newly minted Y Combinator companies get funded as agents and dev tools storm the latest batch. Elon Musk rolls the dice with Austin robotaxis. Chime’s IPO a big win for some investors, not others, while Stripe and Automattic help ease the M&A drought.

  • 3 weeks ago | newcomer.co | Jonathan Weber |Madeline Renbarger

    This Week in ShortOpenAI’s move to buy Windsurf prompted Anthropic to cut off the coding app — a sign of whats to come. One thing we can be confident of is crazy AI growth, per Mary Meeker’s “Trends” report. A wave of IPOs continued with a big pop for stablecoin provider Circle on Thursday, and M&A is picking up too. AI video is suddenly everywhere as both Hollywood dealmaker Jeffrey Katzenberg and Meta back tools for AI video ads.

  • 4 weeks ago | newcomer.co | Madeline Renbarger

    The Week In ShortHinge Health’s IPO was a big win for early investors Insight Partners, Atomico, 11.2 Capital, and Bessemer Venture Partners, but less so for late-stage ones. Now, other healthtechs are cautiously awaiting their public debuts. Emerging fund managers are in dire straits, per Bloomberg’s Kate Clark and Katie Roof. The team at Grammarly gets a billion dollar boost from Pranav Singhvi’s Customer Value Fund. Plus, our investor spotlights featuring Jim Breyer and Leigh Marie Braswell.

  • 1 month ago | newcomer.co | Eric Newcomer |Madeline Renbarger

    The race to back the next big AI startup for healthcare is heating up. OpenEvidence, a Sequoia-backed AI medical assistant for doctors, is raising over $100 million in fresh funding at a $3 billion valuation, sources tell us. GV and Kleiner Perkins are in talks to lead the funding round. The round isn’t finalized and the total amount of funding could increase, sources tell us. OpenEvidence works like a more medically-savvy ChatGPT.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Coverage map

X (formerly Twitter)

Followers
3K
Tweets
1K
DMs Open
Yes
Madeline Renbarger
Madeline Renbarger @maddierenbarger
6 Jun 25

RT @WeberWest: Fun to be working as editor at large for Newcomer, with old colleagues @EricNewcomer and @cityofthetown, and newer colleagu…

Madeline Renbarger
Madeline Renbarger @maddierenbarger
6 Jun 25

SCOOP: SpaceX financials show Musk will be insulated from retaliation from Trump for now @EricNewcomer @cityofthetown https://t.co/CQ4kLeQMZt

Madeline Renbarger
Madeline Renbarger @maddierenbarger
6 Jun 25

RT @EricNewcomer: Let’s get the obvious out of the way: The Trump-Musk breakup was inevitable, dramatic and — no matter your politics — dee…